ACM
Atika Capital Management Portfolio holdings
AUM
$957M
This Quarter Return
+22.87%
1 Year Return
+61.67%
3 Year Return
+345.35%
5 Year Return
+907.8%
10 Year Return
+13,504.21%
AUM
$449M
AUM Growth
+$449M
(+28%)
Cap. Flow
+$67.3M
Cap. Flow
% of AUM
14.99%
Top 10 Holdings %
Top 10 Hldgs %
29.99%
Holding
96
New
27
Increased
17
Reduced
20
Closed
16
Top Buys
| 1 |
CarMax
KMX
|
$13M |
| 2 |
Beyond Meat
BYND
|
$11.4M |
| 3 |
Walt Disney
DIS
|
$8.52M |
| 4 |
HEICO Class A
HEI.A
|
$7.96M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$7.05M |
Top Sells
| 1 |
Madison Square Garden
MSGS
|
$6.89M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
$6.12M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$4.78M |
| 4 |
Ashland
ASH
|
$4.72M |
| 5 |
Boeing
BA
|
$4.58M |
Sector Composition
| 1 | Healthcare | 37.06% |
| 2 | Technology | 23.25% |
| 3 | Communication Services | 13.16% |
| 4 | Consumer Discretionary | 12.57% |
| 5 | Materials | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Guardant Health
GH
$8.41B
| $4.06M | 0.8% |
47,000
-10,000
| -18% | -$863K |
|
52
Veracyte
VCYT
$2.39B
| $3.91M | 0.77% |
+137,000
| New | +$3.91M |
|
|
GOOS
53
Canada Goose Holdings
GOOS
$1.26B
| $3.87M | 0.76% |
100,000
-25,000
| -20% | -$968K |
|
54
Brink's
BCO
$4.67B
| $3.82M | 0.75% |
+47,000
| New | +$3.82M |
|
|
TWTR
55
DELISTED
Twitter, Inc.
TWTR
| $3.49M | 0.69% |
+100,000
| New | +$3.49M |
|
|
ARQL
56
DELISTED
Arqule Inc
ARQL
| $3.49M | 0.69% |
+317,000
| New | +$3.49M |
|
57
PTC Therapeutics
PTCT
$3.92B
| $3.38M | 0.66% |
+75,000
| New | +$3.38M |
|
58
Zoom
ZM
$24.4B
| $3.29M | 0.65% |
+37,000
| New | +$3.29M |
|
|
59
Ashland
ASH
$2.57B
| $3.04M | 0.6% |
38,000
-59,000
| -61% | -$4.72M |
|
|
PTLA
60
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.71M | 0.53% |
100,000
| – | – |
|
|
MDCO
61
DELISTED
Medicines Co
MDCO
| $2.59M | 0.51% |
+71,000
| New | +$2.59M |
|
|
VAR
62
DELISTED
Varian Medical Systems, Inc.
VAR
| $2.59M | 0.51% |
19,000
-30,000
| -61% | -$4.08M |
|
63
Galapagos
GLPG
$2.07B
| $2.45M | 0.48% |
19,000
| – | – |
|
64
NovoCure
NVCR
$1.38B
| $2.09M | 0.41% |
32,990
-25,010
| -43% | -$1.58M |
|
|
ZGNX
65
DELISTED
Zogenix, Inc.
ZGNX
| $1.91M | 0.38% |
40,000
-36,000
| -47% | -$1.72M |
|
66
Anterix
ATEX
$445M
| $1.79M | 0.35% |
38,000
| – | – |
|
67
Ultragenyx Pharmaceutical
RARE
$2.89B
| $1.78M | 0.35% |
+28,000
| New | +$1.78M |
|
68
Molina Healthcare
MOH
$9.8B
| $1.72M | 0.34% |
12,000
-9,000
| -43% | -$1.29M |
|
69
Rocket Pharmaceuticals
RCKT
$354M
| $1.54M | 0.3% |
+102,600
| New | +$1.54M |
|
70
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – |
0
| – | – |
|
71
Apple
AAPL
$3.45T
| – | – |
0
| – | – |
|
|
ALLK
72
DELISTED
Allakos
ALLK
| – | – |
0
| – | – |
|
|
73
Boeing
BA
$177B
| – | – |
-12,000
| Closed | -$4.58M |
|
74
BioMarin Pharmaceuticals
BMRN
$11.2B
| – | – |
-34,500
| Closed | -$3.06M |
|
75
iShares MSCI EAFE ETF
EFA
$66B
| – | – |
0
| – | – |
|